SIC 3826 – Laboratory Analytical Instruments
Valuation | |
---|---|
Market Cap ($M) | 17,350.44 |
Enterprise Value ($M) | 22,624.14 |
Book Value ($M) | 5,252.60 |
Book Value / Share | 7.74 |
Price / Book | 3.30 |
NCAV ($M) | -5,335.20 |
NCAV / Share | -7.87 |
Price / NCAV | -3.25 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.05 |
Current Ratio | 1.61 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,384.90 |
Assets | 12,972.70 |
Liabilities | 7,720.10 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6,967.20 |
Operating Income | 857.20 |
Net Income | 321.10 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 870.00 |
Cash from Investing | -143.70 |
Cash from Financing | -843.70 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Price T Rowe Associates Inc /md/ | 2.90 | 0.00 | |
13G/A | T. Rowe Price Investment Management, Inc. | 7.80 | -31.01 | |
13G/A | Vanguard Group Inc | 9.66 | 5.81 | |
13G | Dodge & Cox | 9.00 | ||
13G/A | BlackRock Inc. | 6.80 | 16.48 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
319,819 | 3,433,515 | 9.31 | |
426,684 | 4,851,094 | 8.80 | |
425,862 | 4,047,874 | 10.52 | |
361,568 | 6,739,416 | 5.36 | |
(click for more detail) |
Similar Companies | |
---|---|
A – Agilent Technologies, Inc. | AME – AMETEK, Inc. |
BIO – Bio-Rad Laboratories, Inc. | BIO.B – Bio-Rad Laboratories, Inc. |
Financial data and stock pages provided by
Fintel.io